ERYN MCMICHAEL: Open Payments
NPI 1225788870 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 37 payments from 18 companies in 2025. Trend: 2023 $1,025 · 2024 $2,378 · 2025 $1,073
Food & beverage: $886Education: $187
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| AstraZeneca Pharmaceuticals LP | 4 | $150 |
| BeOne Medicines USA, Inc. | 2 | $140 |
| Exelixis Inc. | 2 | $119 |
| Janssen Biotech, Inc. | 4 | $100 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Eisai Inc. | 3 | $66 |
| Bard Peripheral Vascular, Inc. | 1 | $39 |
| Genmab U.S., Inc. | 1 | $34 |
| ARRAY BIOPHARMA INC | 1 | $28 |
Products named: Enhertu, TEVIMBRA, KISQALI, Lenvima, TALVEY, SCEMBLIX, Trek, CARVYKTI.
Industry payments across VA — which companies pay providers there.
